GABLES CAPITAL MANAGEMENT INC.
Position in UNCY — Unicycive Therapeutics, Inc.
CIK 1740839
MIAMI, FL
Position in UNCY
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$14,070
New position
Shares Held
3,000
first reported quarter
Ownership
0.011%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#59
of 80 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026GABLES CAPITAL MANAGEMENT INC. holds $190,385 across 9 Biotechnology names. UNCY ranks #3 (7.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CRSP |
CRISPR Therapeutics AG
|
2,000 | $109,080 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
121 | $60,104 | |
| 3 | UNCY |
Unicycive Therapeutics, Inc.
This page
|
3,000 | $14,070 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
21 | $5,060 | |
| 5 | IDYA |
IDEAYA Biosciences, Inc.
|
50 | $1,863 | |
| 6 | FTRE |
Fortrea Holdings Inc.
|
10 | $174 | |
| 7 | CVM |
Cel Sci Corp
|
26 | $27 | |
| 8 | LEXX |
Lexaria Bioscience Corp.
|
1 | $7 |
All Filings in UNCY
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $14,070 | 3,000 | Shares | Sole | 2026-08-10 | |
| No filing history on record for this holder in this stock. | ||||||